Literature DB >> 9063671

Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy.

P E Verweij, N J Cox, J F Meis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9063671     DOI： 10.1007/bf01575117

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  13 in total

1.  Isolation of potentially pathogenic fungi from polluted water and sewage.

Authors:  W B COOKE; P KABLER
Journal:  Public Health Rep       Date:  1955-07       Impact factor: 2.792

2.  Soil as natural reservoir for human pathogenic fungi.

Authors:  L AJELLO
Journal:  Science       Date:  1956-05-18       Impact factor: 47.728

3.  In-vitro studies with SF 86-327, a new orally active allylamine derivative.

Authors:  S Shadomy; A Espinel-Ingroff; R J Gebhart
Journal:  Sabouraudia       Date:  1985-04

4.  Successful treatment of pulmonary pseudallescheriasis with itraconazole.

Authors:  M V Stolk-Engelaar; N J Cox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

5.  Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.

Authors:  S L Goldberg; D J Geha; W F Marshall; D J Inwards; H C Hoagland
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

6.  Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.

Authors:  V V Villars; T C Jones
Journal:  Br J Dermatol       Date:  1992-02       Impact factor: 9.302

7.  Antifungal activity of the allylamine derivative terbinafine in vitro.

Authors:  G Petranyi; J G Meingassner; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

8.  Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.

Authors:  L I Lutwick; J N Galgiani; R H Johnson; D A Stevens
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

9.  Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.

Authors:  T J Walsh; J Peter; D A McGough; A W Fothergill; M G Rinaldi; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient.

Authors:  C C Hung; S C Chang; P C Yang; W C Hsieh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267
View more
  9 in total

1.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.

Authors:  C Girmenia; G Luzi; M Monaco; P Martino
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.

Authors:  Eric Dannaoui; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 6.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.

Authors:  William J Steinbach; Wiley A Schell; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 7.  Invasive mold infections in solid organ transplant recipients.

Authors:  Yoann Crabol; Olivier Lortholary
Journal:  Scientifica (Cairo)       Date:  2014-11-23

8.  Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections.

Authors:  Andrés F Henao-Martínez; José R Castillo-Mancilla; Michelle A Barron; Aran Cunningham Nichol
Journal:  Case Rep Infect Dis       Date:  2013-04-29

Review 9.  Rare fungal infectious agents: a lurking enemy.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  F1000Res       Date:  2017-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.